Ticker

Analyst Price Targets — MDXH

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
August 21, 2026 11:33 am—BTIG$2.00$0.72TheFly MDxHealth price target lowered to $2 from $4 at BTIG
August 14, 2026 12:51 pm—Lake Street$3.00$1.01TheFly MDxHealth price target lowered to $3 from $5 at Lake Street
May 14, 2026 11:29 am—BTIG$4.00$1.95TheFly MDxHealth price target lowered to $4 from $7 at BTIG
August 26, 2022 8:03 amMark MassaroBTIG$15.00$8.19TheFly MDxHealth price target raised to $15 from $13 at BTIG

Latest News for MDXH

MDxHealth Announces Preliminary Third Quarter 2026 Revenue and Suspends Full-Year 2026 Revenue Guidance

IRVINE, CA – October 15, 2026 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leader in urology-focused precision diagnostics, today announced preliminary unaudited revenue from continuing operations for the third quarter ended September 30, 2026, and suspends its full-year 2026 revenue guidance of $110–115 million. The Company expects to report third quarter 2026 revenue from…

GlobeNewsWire • Oct 15, 2026
Comparing MDxHealth (NASDAQ:MDXH) & Shattuck Labs (NASDAQ:STTK)

Shattuck Labs (NASDAQ: STTK - Get Free Report) and MDxHealth (NASDAQ: MDXH - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings and dividends. Risk and Volatility Shattuck Labs has a beta

Defense World • Oct 2, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for MDXH.

No House trades found for MDXH.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top